The papers that
changed everything.
From a single discovery in 1962 to the first human trial in 2026. Seven decades of evidence, in plain English.
The Foundation
1957 - 2015The Strategy of the Genes
Waddington, C.H. · George Allen & Unwin (book)
Introduced the "epigenetic landscape" metaphor -- a ball rolling through valleys of cell fate. The conceptual foundation for understanding reprogramming as movement through epigenetic state space.
Read paperThe Developmental Capacity of Nuclei taken from Intestinal Epithelium Cells of Feeding Tadpoles
Gurdon, J.B. · J. Embryol. Exp. Morphol.
Proved that differentiated somatic cell nuclei retain full genetic information for development -- the conceptual origin of reprogramming.
Read paperInduction of Pluripotent Stem Cells from Mouse Embryonic and Adult Fibroblast Cultures by Defined Factors
Takahashi & Yamanaka · Cell
Identified four transcription factors (Oct3/4, Sox2, c-Myc, Klf4) that reprogram mouse fibroblasts into iPSCs. Nobel Prize-winning work that launched the field.
Read paperInduction of Pluripotent Stem Cells from Adult Human Fibroblasts by Defined Factors
Takahashi, Tanabe, Ohnuki et al. · Cell
Extended iPSC technology to human cells, showing the same four Yamanaka factors reprogram adult human fibroblasts into pluripotent stem cells.
Read paperAging, Rejuvenation, and Epigenetic Reprogramming: Resetting the Aging Clock
Rando & Chang · Cell
Landmark review defining youthfulness and senescence as epigenetic states, proposing that the aging clock can be reversed through epigenetic reprogramming.
Read paperThe Hallmarks of Aging
Lopez-Otin, Blasco, Partridge et al. · Cell
Defined the nine hallmarks of aging, including epigenetic alterations. The unifying framework connecting reprogramming to aging.
Read paperPluripotent Stem Cells Induced from Mouse Somatic Cells by Small-Molecule Compounds
Hou, Li, Zhang et al. (Deng lab) · Science
First demonstration that pluripotent stem cells can be generated from somatic cells using only seven small-molecule compounds -- no transcription factors needed.
Read paperDNA Methylation Age of Human Tissues and Cell Types
Horvath, S. · Genome Biology
The first multi-tissue epigenetic clock: 353 CpG sites predicting chronological age across 51 tissues (r = 0.97). The foundational biomarker for biological age.
Read paperGenome-wide Methylation Profiles Reveal Quantitative Views of Human Aging Rates
Hannum, Guinney, Zhao et al. · Molecular Cell
Built a quantitative model of aging using 71 key CpG markers from 656 blood samples, establishing the Hannum epigenetic clock and showing aging rates vary by gender and genetics.
Read paperReprogramming In Vivo Produces Teratomas and iPS Cells with Totipotency Features
Abad, Mosteiro, Pantoja et al. (Serrano lab) · Nature
Continuous in vivo OSKM causes teratomas across multiple organs -- establishing why partial/transient reprogramming is necessary instead of full reprogramming.
Read paperThe Acceleration
2016 - 2022In Vivo Amelioration of Age-Associated Hallmarks by Partial Reprogramming
Ocampo, Reddy, Martinez-Redondo et al. · Cell
The foundational partial reprogramming paper. Cyclic OSKM (2 days on, 5 off) reversed aging hallmarks and extended lifespan by ~30% in progeroid mice without teratomas.
Read paperTissue Damage and Senescence Provide Critical Signals for Cellular Reprogramming In Vivo
Mosteiro, Pantoja, Alcazar et al. (Serrano lab) · Science
In vivo OSKM simultaneously induces senescence and reprogramming. Senescence through Ink4a/Arf and IL-6 creates a permissive environment, revealing the link between tumor suppression and reprogramming.
Read paperAn Epigenetic Biomarker of Aging for Lifespan and Healthspan (PhenoAge)
Levine, Lu, Quach et al. · Aging
DNAm PhenoAge: 513 CpGs optimized for phenotypic age rather than chronological, outperforming prior clocks at predicting mortality, cancer, and Alzheimer's risk.
Read paperDNA Methylation-Based Biomarkers and the Epigenetic Clock Theory of Ageing
Horvath & Raj · Nature Reviews Genetics
Comprehensive review unifying epigenetic clocks under a theory linking developmental and maintenance processes to biological aging across the life course.
Read paperPartial Reprogramming Induces a Steady Decline in Epigenetic Age Before Loss of Somatic Identity
Olova, Simpson, Marioni & Chandra · Aging Cell
Mapped a "safe window" (days 3-13) where epigenetic age declines ~10-20+ years before cell identity is lost, proving rejuvenation and dedifferentiation can be uncoupled.
Read paperDNA Methylation GrimAge Strongly Predicts Lifespan and Healthspan
Lu, Quach, Wilson et al. (Horvath lab) · Aging
GrimAge: trained on time-to-death data with 8 methylation-based surrogate markers. Outperforms all prior clocks for predicting mortality, heart disease, and cancer.
Read paperReprogramming to Recover Youthful Epigenetic Information and Restore Vision
Lu, Brommer, Tian et al. (Sinclair lab) · Nature
OSK (without c-Myc) restored youthful DNA methylation, promoted axon regeneration, and reversed vision loss in glaucoma and aged mice. No tumors over 10-18 months.
Read paperIn Vivo Reprogramming Ameliorates Aging Features in Dentate Gyrus Cells and Improves Memory in Mice
Rodriguez-Matellan, Alcazar, Hernandez et al. · Stem Cell Reports
Cyclic OSKM in the dentate gyrus elevated neurogenesis markers, increased NMDA receptor subunits, and improved object recognition memory in wildtype mice.
Read paperTransient Non-Integrative Expression of Nuclear Reprogramming Factors Promotes Multifaceted Amelioration of Aging in Human Cells
Sarkar, Quarta, Mukherjee et al. · Nature Communications
mRNA-mediated transient OSKM+LIN28+NANOG in aged human cells reset the epigenetic clock, reduced inflammation, and restored youthful regenerative responses without full dedifferentiation.
Read paperPrevention of Tumor Risk Associated with the Reprogramming of Human Pluripotent Stem Cells
Lee, Tang, Rao et al. · J. Exp. Clin. Cancer Research
Comprehensive review of strategies to prevent tumor risk in iPSC therapies: c-Myc exclusion, suicide gene systems, and selection methods for clinical translation.
Read paperReversible Reprogramming of Cardiomyocytes to a Fetal State Drives Heart Regeneration in Mice
Chen, Luttmann, Schoger et al. · Science
Heart-specific transient OSKM induced cardiomyocyte dedifferentiation to a fetal-like state, conferring regenerative capacity and improving cardiac function after infarction.
Read paperCellular Reprogramming and Epigenetic Rejuvenation
Simpson, Olova & Chandra · Clinical Epigenetics
Reviews the strategy of epigenetic rejuvenation -- separating rejuvenation from dedifferentiation. Discusses transient expression, OSK vs. OSKM, and the safe window concept.
Read paperA Single Short Reprogramming Early in Life Initiates and Propagates an Epigenetically Related Mechanism Improving Fitness and Promoting an Increased Healthy Lifespan
Alle, Le Borgne, Bensadoun et al. · Aging Cell
A single OSKM pulse at 2 months of age prevented musculoskeletal deterioration and increased lifespan by ~15% in old age -- implying a deep, persistent epigenetic memory of early-life reprogramming.
Read paperIn Vivo Partial Reprogramming Alters Age-Associated Molecular Changes During Physiological Aging in Mice
Browder, Reddy, Yamamoto et al. · Nature Aging
First study in naturally aging wildtype mice. Long-term cyclic OSKM reversed the epigenetic clock in kidney and skin, reduced inflammation and senescence.
Read paperMulti-omic Rejuvenation of Naturally Aged Tissues by a Single Cycle of Transient Reprogramming
Chondronasiou, Gill, Vaquero et al. · Aging Cell
A single 1-week transient OSKM expression reversed DNA methylation changes in pancreas, liver, spleen, and blood of naturally aged wildtype mice.
Read paperMulti-omic Rejuvenation of Human Cells by Maturation Phase Transient Reprogramming
Gill, Parry, Santos et al. (Reik lab) · eLife
Developed "maturation phase transient reprogramming" -- rejuvenated the transcriptome of human fibroblasts by ~30 years, restored youthful collagen production, and partially restored migration speed.
Read paperChemical Reprogramming of Human Somatic Cells to Pluripotent Stem Cells
Guan, Wang, Wang et al. (Deng lab) · Nature
Extended chemical reprogramming to human cells for the first time, generating human chemically induced pluripotent stem cells from somatic cells without genetic factors.
Read paperThe Clinic
2023 - 2026Hallmarks of Aging: An Expanding Universe
Lopez-Otin, Blasco, Partridge et al. · Cell
Updated the hallmarks to twelve, adding disabled macroautophagy, chronic inflammation, and dysbiosis. The most current organizing framework for aging biology.
Read paperLoss of Epigenetic Information as a Cause of Mammalian Aging
Yang, Hayano, Griffin et al. (Sinclair lab) · Cell
Using an ICE mouse model, showed that faithful DNA repair erodes the epigenetic landscape and drives aging. OSK reprogramming reverses these changes, supporting the "Information Theory of Aging."
Read paperThe Information Theory of Aging
Lu, Tian & Sinclair · Nature Aging
Formalizes the Information Theory of Aging: aging is driven by progressive loss of youthful epigenetic information, retrievable via epigenetic reprogramming.
Read paperHighly Efficient and Rapid Generation of Human Pluripotent Stem Cells by Chemical Reprogramming
Yang, Wang et al. (Deng lab) · Cell Stem Cell
Shortened chemical reprogramming from ~50 to 16 days with reproducible efficiency across 17 donors, making chemical reprogramming clinically tractable.
Read paperChemically Induced Reprogramming to Reverse Cellular Aging
Yang, Petty, Dixon-McDougall et al. (Sinclair lab) · Aging
Identified six chemical cocktails that restore youthful transcript profiles and reverse transcriptomic age in human cells within 4 days, without genetic factors.
Read paperGene Therapy-Mediated Partial Reprogramming Extends Lifespan and Reverses Age-Related Changes in Aged Mice
Macip, Czajka, Selber-Hnatiw et al. · Cellular Reprogramming
AAV-delivered inducible OSK extended median remaining lifespan by 109% in extremely aged (124-week) mice with significant age-reversal in heart and liver.
Read paperTargeted Partial Reprogramming of Age-Associated Cell States Improves Markers of Health in Mouse Models of Aging
Macip, Hasan, Houghton et al. · Science Translational Medicine
Targeted OSK to senescent cells via AAV, achieving a 12% lifespan extension in wildtype mice -- the largest by partial reprogramming in wildtype mice to date.
Read paperExpansion of the Neocortex and Protection from Neurodegeneration by In Vivo Transient Reprogramming
Shen, Zaballa, Bech et al. · Cell Stem Cell
Controlled Yamanaka factor induction in the brain expanded upper cortical neurons, enhanced behavior, and prevented Alzheimer's hallmarks in the 5xFAD model.
Read paperPartial Cellular Reprogramming: A Deep Dive into an Emerging Rejuvenation Technology
Paine, Nguyen & Ocampo · Aging Cell
Comprehensive review of partial reprogramming's aging-related benefits, examining how reprogramming modulates cell fate and cellular age while preserving cell identity.
Read paperThe Long and Winding Road of Reprogramming-Induced Rejuvenation
Ruetz, Pogson, Bhatt et al. · Nature Communications
Critical review comparing partial reprogramming, full reprogramming, and transdifferentiation approaches. Assesses safety concerns and translational barriers.
Read paperMechanisms, Pathways and Strategies for Rejuvenation Through Epigenetic Reprogramming
Cipriano, A., Moqri, M., Maybury-Lewis, S.Y. et al. · Nature Aging
Reviews the mechanisms by which transient reprogramming factors achieve rejuvenation at cellular, tissue, and organismal levels. Evaluates translational potential.
Read paperCellular Plasticity in Reprogramming, Rejuvenation and Tumorigenesis: A Pioneer TF Perspective
Huyghe, A., Trajkova, A. and Lavial, F. · Trends in Cell Biology
Examines the role of pioneer transcription factors (Oct4, Sox2, Klf4) in both rejuvenation and tumorigenesis, parsing the critical differences that determine outcome.
Read paperChemical Reprogramming Ameliorates Cellular Hallmarks of Aging and Extends Lifespan
Schoenfeldt, L., Paine, P.T., Pico, S. et al. · EMBO Molecular Medicine
A seven-compound cocktail reverses aging hallmarks in human fibroblasts; a reduced two-compound subset extended median lifespan by 42% in C. elegans.
Read paperSenescence-Resistant Human Mesenchymal Progenitor Cells Counter Aging in Primates
Lei, J., Xin, Z., Liu, N. et al. · Cell
FOXO3-engineered cells delivered to aged macaques improved cognition, preserved brain structure, rejuvenated immunity, and reversed biological age across multiple tissues.
Read paperPrevalent Mesenchymal Drift in Aging and Disease is Reversed by Partial Reprogramming
Lu et al. (Sinclair lab) · Cell
Identified a pervasive "mesenchymal drift" across 40+ tissues and 20 diseases. Higher drift correlates with worse outcomes. Partial reprogramming markedly reduces it.
Read paperPartial Reprogramming by Cyclical Overexpression of Yamanaka Factors Improves Pathological Phenotypes of Tauopathy Mouse Model of Human Alzheimer's Disease
Anton-Fernandez, A., Ruiz de Alegria, A., Mariscal-Casero, A. et al. · Progress in Neurobiology
Cyclical OSKM improved pathological phenotypes in an Alzheimer's tauopathy model, demonstrating therapeutic potential for neurodegenerative diseases.
Read paperCognitive Rejuvenation Through Partial Reprogramming of Engram Cells
Berdugo-Vega et al. (EPFL) · Neuron
Targeted OSK at engram (memory trace) neurons in aged and Alzheimer's mice, recovering learning and memory to youthful levels by re-establishing synaptic plasticity.
Read paperThe Epigenetic Rejuvenation Promise: Partial Reprogramming as a Therapeutic Strategy for Aging and Disease
Li, Y.Y. and Tay, F.R. · Ageing Research Reviews
Comprehensive review of how partial reprogramming resets epigenetic age and opens therapeutic opportunities for degenerative diseases without tumorigenic risks.
Read paperRedefining Cellular Reprogramming with Advanced Genomic Technologies
Morris, S.A. · Nature Reviews Genetics
Reviews how single-cell genomics and molecular recording tools are revealing mechanisms of incomplete reprogramming, highlighting targetable failure points for rejuvenation therapies.
Read paper“The evidence is no longer theoretical — it is clinical, reproducible, and accelerating.”
THIS TIMELINE WILL GROW AS NEW BREAKTHROUGHS EMERGE.